Steiner laboratories awarded United States patent for anticraving agent.

Effective medications for the treatment of addictions are rare. Patent approval for anticraving agents are even rarer. NEUROTONEN, researched and developed by STEINER LABORATORIES, has received recent patent approval for the treatment of the craving for substances of abuse. While the research focused on the use of NEUROTONEN for the treatment of craving for all addictions the patent specifically focuses on the use of NEUROTONEN as an anticraving agent for alcohol.

Treatment for the cravings of alcohol addiction.

A major symptom of addiction is the craving that drives the person to take the substance of abuse. Our research goal was to find and develop an anticraving agent to stop the craving of alcohol addiction. NEUROTONEN has been shown to make a statically significant reduction in alcohol craving. In a double blind study of patients suffering from long-term addiction to alcohol, NEUROTONEN resulted in a statically significant reduction in alcohol craving and a significant increase in abstinence from drinking when compared with the control group. The results of these studies were confirmed by studies performed at the Pernod Ricard Research Centre, Creteil, France. It is advised that everyone taking this NEUROTONEN should be under the care of a health professional and participating in a treatment program. If you or your health professional have any questions please contact us at *

Directions and Dosage:

There are two phases that should be followed while taking NEUROTONEN

INITIAL PHASE: For one month take one or two tables four times each day. If preferred, NEUROTONEN can be taken with meals but take the last dose two hours before sleep.
MAINTENANCE PHASE: After two weeks of abstinence from alcohol NEUROTONEN can be modified to the particular needs of the individual. Different people find different times during the day or different social settings more difficult. In these instances taking NEUROTONEN can help reduce craving for alcohol without the need to take NEUROTONEN continually. Allow 45 minutes after taking NEUROTONEN to feel relaxed with reduced craving. When the craving is resolved you can safely stop taking NEUROTONEN. Without the craving for the substance of abuse a person then has the ability to limit consumption and is no longer addicted.

Key Benefits

• REDUCES CRAVING
• RESULTS IS A SIGNIFICANT INCREASE IN ABSTENANCE
• REDUCES THE ANXIETY ASSOCIATED WITH WITHDRAWAL

Click here for pricing and ordering information.

*The FDA has not evaluated this statement. This product is not intended to diagnose, treat, cure or prevent any disease.